Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...

Overview of the Cardiovascular System

Overview of the Cardiovascular System

The cardiovascular system is a vital transportation system in the body. It comprises the heart and blood vessels and facilitates the exchange of gases, nutrients, and waste products.
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...

Regulation of the Cardiovascular System

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

Exercise and Cardiovascular Response

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...

Assessment of the Cardiovascular System II: Inspection

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck

Assessment of the Cardiovascular System IV: Auscultation

Assessment of the Cardiovascular System IV: Auscultation

Cardiac auscultation is a clinical skill used to assess heart function and detect abnormalities. It involves listening to heart sounds at specific anatomical locations through a stethoscope.
Normal Heart Sounds
S1 (First Heart Sound)-
S1 is made by the closure of the mitral and tricuspid valves (atrioventricular valves), marking the beginning of systole.
S2 (Second Heart Sound)-
S2 is made by the closure of the aortic and pulmonic valves (semilunar valves), marking the end of the systole.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Left ventricular excessive trabeculation: pathophysiology, diagnostic challenges, and prognostic significance.

Heart failure reviews·2026

Same author

Beyond vasodilation: sotatercept and the remodeling hypothesis in hfpef-associated pulmonary hypertension.

Heart failure reviews·2026

Same author

Across Clinical Profiles of Cardiorenal-Metabolic (CKM) Syndrome: A Phenotype-Driven Therapeutic Approach.

Biomedicines·2026

Same author

The spectrum of congestion in heart failure: underlying pathophysiology and diagnostic strategies.

Heart failure reviews·2026

Same author

Tirzepatide versus dulaglutide in heart failure: another SURPASS attempt yielding a tie.

Heart failure reviews·2026

Same author

Long-term outcomes following sacubitril/valsartan therapy for chronic HFrEF: an Italian real-world multicentre study.

ESC heart failure·2026

Search research articles

Related Experiment Video

Updated: Feb 3, 2026

In Silico Clinical Trials for Cardiovascular Disease

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

Hyperuricemia and Cardiovascular Disease.

Alberto Palazzuoli¹, Helen Hashemi², Lauren C Jameson³

¹Cardiology Unit, Department of Internal Medicine, University of Siena, Italy.

Reviews in Cardiovascular Medicine

|November 7, 2018

Summary

High uric acid (UA) levels are linked to cardiovascular disease. Lowering UA may reduce risks of heart attack, stroke, and heart failure, improving cardiovascular health.

More Related Videos

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

Dissection Techniques and Histological Sampling of the Heart in Large Animal Models for Cardiovascular Diseases

Dissection Techniques and Histological Sampling of the Heart in Large Animal Models for Cardiovascular Diseases

Published on: June 16, 2022

Related Experiment Videos

Last Updated: Feb 3, 2026

In Silico Clinical Trials for Cardiovascular Disease

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

Dissection Techniques and Histological Sampling of the Heart in Large Animal Models for Cardiovascular Diseases

Dissection Techniques and Histological Sampling of the Heart in Large Animal Models for Cardiovascular Diseases

Published on: June 16, 2022

Area of Science:

Biochemistry
Cardiology
Metabolic Disorders

Background:

Uric acid (UA) is a metabolic byproduct linked to gout and kidney stones.
Hyperuricemia, or high UA levels, is increasingly recognized as a cardiovascular risk factor.
UA is associated with conditions like hypertension, myocardial infarction, metabolic syndrome, and heart failure.

Purpose of the Study:

To explore the pathophysiology of hyperuricemia.
To describe the biological mechanisms connecting UA to cardiovascular disease development.
To discuss the potential benefits of reducing plasma UA for cardiovascular event prevention.

Main Methods:

Literature review of existing studies on uric acid and cardiovascular health.
Analysis of the pathophysiological pathways involved in hyperuricemia.
Examination of biological plausibility for UA's role in cardiovascular pathogenesis.

Main Results:

Hyperuricemia is a common metabolic disorder with clear links to cardiovascular diseases.
Several cardiovascular conditions are associated with elevated uric acid levels.
The article details the biological rationale for UA's involvement in cardiovascular disease.

Conclusions:

Lowering plasma uric acid concentrations is a potential strategy to reduce cardiovascular risk.
Reducing UA may decrease the incidence of myocardial infarction, stroke, and heart failure.
Managing hyperuricemia could be crucial for preventing cardiovascular death.